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Introduction
Stomach cancer is one of the most important causes 
of cancer-related deaths worldwide and a major cause 
of cancer death in Asia (1). Treatment options for 
these patients include chemotherapy and surgery. But, 
therapeutic effects of chemotherapeutic drugs are not 
good enough and these drugs have many side effects (2). 
In recent years, a lot of researches have been done on drugs 
that might have protective or therapeutic effects against 
stomach cancer (3). Various flavonoids have been found 
to inhibit the development of cancer. Epidemiological 
studies have also shown that consumption of dietary 
flavonoids in fruits and vegetables may help reduce the 
incidence of cancer. This issue has been confirmed on in 
vivo and in vitro studies (4). Several mechanisms of action 
have been proposed for the effect of flavonoids including 
carcinogens inactivation, inhibition of angiogenesis and 
elimination of drug resistance or a combination of these 
mechanisms. Damage to healthy cells and development 
of cellular resistance to anticancer drugs restrict the use 
of chemotherapy drugs. All of these suppose the use of 
flavonoids for future clinical studies (5). Chrysin is a 
natural flavonoid compound extracted from honey, 
plants and propolis and been shown to possess anti-
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Introduction: Chrysin is a natural flavonoid antioxidant which its role in tumor cell death has 
been reported. The aim of this study was to investigate the mechanism of Chrysin effect on 
proliferation and apoptosis of gastric cancer cell line (AGS).
Methods: Cells were cultured and treated with different concentrations of Chrysin (90, 80, 70, 
60, 50 µM) for 48 h and evaluated for cell viability. To examine the cytotoxic effect of drug in 
inducing apoptosis, staining with fluorescein isothiocyanate (FITC) and propidium iodide (PI) 
was used.  The cells were treated for 48 h with different concentrations of Chrysin (50 of 90 µM) 
and examined for the morphological changes. The one-way analysis of variance (ANOVA) and the 
Excel software were used for data analysis. 
Results: Different concentrations of Chrysin significantly inhibited the growth and proliferation 
of AGS cells (p<0.05). The IC50 dose was determined to be 67.5±0.66. Apoptosis induced by 50 and 
70 µM of Chrysin was significantly greater than in untreated cells (p<0.05). Cells treated with high 
concentration of Chrysin (90 µM) showed more prominent growth inhibition and cell shrinkage 
compared to cells treated with the lower concentrations of Chrysin.
Conclusion: The results of this study showed that Chrysin effects on AGS cell line were significantly 
high and dose-dependent and might be helpful in the treatment of gastric cancer. Chrysin may 
therefore be considered a potential candidate for both cancer prevention and treatment. Further 
investigation is needed to validate the contribution of chrysin in tumor therapy in vivo.
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inflammatory and antioxidant properties (6). The 
potential apoptotic effect of chrysin has been reported 
in human cervical cancer, esophageal squamous cancer, 
malignant glioma, leukemia, breast, prostate and colon 
cancers, in vitro (7). The aim of this in vitro experimental 
study was to investigate the antiproliferative and apoptotic 
effects of Chrysin on gastric cancer cell line (AGS).
Materials and Methods
Cell culture and MTS assay
The AGS cell line (Pasture Institute, Iran) was cultured in 
DMEM medium and supplemented with 10% FBS, 100 
U/ml penicillin, 100 µg/ml streptomycin and glutamine. 
The cells were harvested from the culture medium 
using trypsin (0.25%)-EDTA (0.1%). After washing, the 
number of viable cells was determined by trypan blue 
dye exclusion using a hemocytometer. Cells with viability 
greater than 95% were used for the experiment. MTS assay 
test was performed to determine the effect of chrysin in 
AGS cells. IC50 value which is the drug concentration 
required to kill 50% of the cells was obtained, too. Briefly, 
appropriate numbers of cells (10,000 cells) were cultured 
in 96-well plates. After 24 h incubation, different doses of 
Chrysin (90, 80, 70, 60, 50 µM) were added to each well. 
At least three wells were allocated for each concentration. 
Wells with cells but without drugs served as controls and 
3 wells were used to assess the drug-free control. After 48 
h, MTS test was performed. Cell Titer 96® AQueous One 
Solution Cell Proliferation Assay Kit was used for MTS 
assay according to the manufacturer’s protocol. For this 
purpose, 20 μl of MTS working solution were added to 
each well. When MTS solution was absorbed by living cells 
a formazan product that had an absorbance maximum 
at 450 nms was produced, thus optical density (OD) 
would be the number of cells per well. The absorbance 
(optical density, OD) of formazan was measured using 
spectrophotometry. IC50 value was calculated as the sample 
concentration that caused 50% cell death as compared to 
the control cells (no drug added). 
Assessment of apoptosis
To examine the cytotoxic effect of drug and its 
mechanisms in inducing apoptosis FITC Annexin V 
Apoptosis Detection Kit (BD) was used according to the 
manufacturer’s protocol. Cancer cells were added in each 
well of 6-well plate. After 24 h, cells were treated at dose 
levels higher and lower than the IC50 value of chrysin 
(50 and 70 µM). After 24 h incubation, cells were rinsed 
with cold PBS and re-suspended in 100 µl of binding 
buffer. Then, stained with 5 µl FITC Annexin V and 10 
µl Propidium iodide and incubated for 15 min at room 
temperature in the dark. The cells were examined by flow-
cytometer. Cells that are FITC Annexin V positive and PI 
negative are in early stage of apoptosis; cells that are FITC 
Annexin V and PI positive are in late stage of apoptosis or 
already dead, cell that are FITC Annexin V negative and 
PI positive are considered necrotic. 
Morphological study
The morphological changes of the cells and cells death 
were observed by using a normal inverted microscope. 
Cells were treated for 48 h with different concentrations 
of Chrysin (50 of 90 µM) and then morphological changes 
were examined and recorded.
Statistical analysis
In the present study, AGS cells were divided into two 
groups: Control group that did not receive any treatment 
and a group that received a drug. All experiments were 
carried out in triplicate. All results were expressed as mean 
± SEM. Data were analyzed statistically using the SPSS 
16 software. The one-way analysis of variance (ANOVA) 
was used to determine whether there were any significant 
differences between the means. A probability level of 
p<0.05 was considered statistically significant.
Results
Effects of different concentrations of Chrysin on the cell 
growth and proliferation
Results of the Chrysin effect on the growth and 
proliferation of AGS cell was reported as the average of 
several independent experiments (Figure 1). Different 
concentrations of Chrysin significantly inhibited the 
growth and proliferation of gastric carcinoma cells 
(p<0.05). The IC50 dose was determined to be 67.5±0.66.
Inducing apoptosis in cancer cells treated with Chrysin
In control group (untreated) 0.94% necrosis and 2.48% 
early apoptosis was observed. Induced necrosis, early 
apoptosis and late apoptosis in AGS cells treated with 50 
µM Chrysin respectively were 2.91, 2.21 and 19.3. In cells 
treated with 70 µM Chrysin they were 1.26, 4.23 and 22.9, 
respectively, (Figures 2 and 3). Apoptosis induced by 50 
and 70 µM of Chrysin was significantly greater than in 
untreated cells (p<0.05).
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Figure 1. Effect of chrysin on the cell growth and proliferation. 
The cytotoxicity of AGS was increased significantly with increas-
ing the concentration of chrysin.
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Morphological Evaluation
There were no significant morphological changes after 
24 h of incubation with the low concentration of Chrysin 
(50 µM), but after 48 h of incubation with 50 and 90 
µM of Chrysin, significant changes in morphology were 
observed (Figure 4). Cells treated with high concentration 
of Chrysin (90 µM) compared to cells treated with the 
lower concentrations showed more prominent growth 
inhibition and cell shrinkage.
Discussion
In recent years, considerable efforts have been done 
to identify naturally occurring compound and related 
Figure 3. Induction of apoptosis in AGS cells after 48-hour 
treatment with chrysin. Statistical analysis performed by ANOVA 
followed by post hoc Tukey,S test. Value of **p˂0.001 was 
assumed statistically significant. (ns: not significant and p>0.05)
Figure 4. Morphological changes of cells after treatment with 
different concentrations of chrysin 48 hours post-treatment. 
A) Normal cells; B) 50 mM; and C) 90 mM. Cells treated with 
high concentration of Chrysin (90 µM) compared to cells treated 
with the lower concentrations showed more prominent growth 
inhibition and cell shrinkage.
Figure 2. Flow-cytometry analysis using Annexin V-FITC/PI double staining depicting apoptosis. The cells were treated with 50 and 70 
µM chrysin for 48 h or media only (control), and apoptosis was examined by flow-cytometry after Annexin V-PI double staining. Necrotic 
cells lose membrane integrity, permitting PI entry. Viable cells exhibited Annexin V (-)/PI (-); early apoptotic cells exhibited Annexin (+)/PI 
(-); late apoptotic cells or necrotic cells exhibited Annexin V (+)/PI (+).
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synthetic agents that can prevent the development and 
recurrence of cancer. Several natural compounds have 
been found to induce apoptosis in various tumor cells 
and there are clear evidences that these compounds are 
potent inhibitors of cancer cell proliferation (8). Chrysin 
is a natural flavonoid extracted from honey, propolis (a 
wax) and various plants. It has been reported to have 
potent antioxidant and anti-inflammatory properties and 
promotes cell death by perturbing cell cycle progression. 
In order to determine the effect of Chrysin on gastric 
cancer, its effects on growth and proliferation of human 
gastric adenocarcinoma cell line were assessed in vitro 
using a MTS assay test. The results of this study showed 
that different concentrations of Chrysin markedly inhibit 
growth and proliferation in AGS cells in a dose-dependent 
manner. Inhibition of growth in cancer cells by minimum 
and maximum concentrations of Chrysin (50 and 90 µM) 
were 19.6 and 93.2, respectively. Our results showed that 
Chrysin had significant cytotoxic activity against human 
gastric cancer cells. This is the first report on chrysin-
induced cytotoxicity and apoptosis in human gastric 
adenocarcinoma cell line.
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Xue et al investigated the cytotoxic and antiproliferative 
effects of Chrysin on prostate cancer cell line which is 
in agreement with our results. Their results showed that 
Chrysin exhibited inhibitory effects on angiogenesis 
in mouse model, the critical step of tumor growth and 
metastasis (9). Hong et al reported the anticancer effect 
of Chrysin on MDA-MB231 breast cancer cells. In their 
study, the effect of Chrysin on cells was determined 
24 and 48 h after treatment. 24 h after treatment no 
significant effect was observed, but after 48 h treatment 
with concentrations of 20 and 40 µM respectively 73.9 
and 73.1 viability were observed. Thus, 20 μM Chrysin 
for 48 h was reported as the effective concentration (4). 
In Zhang et al study anticancer effects of Chrysin on 
a human esophageal adenocarcinoma cell line (OE33) 
was investigated and reported IC50 value of Chrysin was 
90 µM. In our study IC50 value of Chrysin was 66 µM 
and it seems that cytotoxic effects of Chrysin on gastric 
cancer cells were much more than those on esophageal 
adenocarcinoma OE33 cells (10).
In the present study, types of cell death (apoptosis or 
necrosis) induced by Chrysin in AGS cells were determined 
by flow-cytometry. Chrysin induced early and late 
apoptosis and necrosis in gastric cancer cells, but the rate 
of late apoptosis was significantly higher. Thus secondary 
apoptosis seems to be the major mechanism of tumor cell 
killing. Therefore, apoptosis plays an important role in 
the anticancer activity of Chrysin. Zheng et al reported 
that Chrysin induces apoptosis human myeloid leukemia 
cell lines by induction of caspases and inactivation of Akt 
(11). In another study, anticancer effects of this drug and 
its derivatives on human gastric cancer cell lines (SGC-
7901) and human colon carcinoma cell lines (HT-29) have 
been reported (12).
Conclusion
The results of our study showed that Chrysin could 
inhibit gastric cancer cells. Further researches are needed 
to fully understand the mechanism of action, in order to 
use in modern therapies as chemotherapy adjuvant in the 
treatment of gastric cancer. Because chemotherapy drugs 
that are used to treat cancer often cause unwanted side-
effects, simultaneous use of various compounds derived 
from medicinal plants may increase effectiveness of other 
drugs in treatment of cancer.
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